Shares

13 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q1 2023

May 15, 2023

SELL
$6.7 - $24.21 $569,553 - $2.06 Million
-85,008 Reduced 32.49%
176,649 $4.26 Million
Q4 2022

Feb 14, 2023

BUY
$4.52 - $10.57 $1.13 Million - $2.64 Million
250,153 Added 2174.49%
261,657 $2.77 Million
Q3 2022

Nov 14, 2022

BUY
$3.43 - $5.62 $39,458 - $64,652
11,504 New
11,504 $52,000
Q2 2022

Aug 16, 2022

SELL
$3.65 - $7.3 $71,762 - $143,525
-19,661 Closed
0 $0
Q1 2022

May 17, 2022

SELL
$3.4 - $7.88 $139,301 - $322,851
-40,971 Reduced 67.57%
19,661 $144,000
Q4 2021

Feb 15, 2022

SELL
$5.59 - $7.39 $101,615 - $134,335
-18,178 Reduced 23.07%
60,632 $340,000
Q3 2021

Nov 16, 2021

SELL
$5.66 - $8.33 $309,573 - $455,609
-54,695 Reduced 40.97%
78,810 $504,000
Q2 2021

Aug 16, 2021

BUY
$6.71 - $11.04 $674,999 - $1.11 Million
100,596 Added 305.68%
133,505 $1.13 Million
Q1 2021

May 18, 2021

BUY
$10.12 - $19.45 $151,648 - $291,458
14,985 Added 83.6%
32,909 $345,000
Q4 2020

Feb 17, 2021

SELL
$11.79 - $18.94 $72,308 - $116,159
-6,133 Reduced 25.49%
17,924 $304,000
Q3 2020

Nov 17, 2020

SELL
$10.34 - $15.2 $154,913 - $227,726
-14,982 Reduced 38.38%
24,057 $309,000
Q2 2020

Aug 17, 2020

SELL
$7.81 - $17.0 $233,230 - $507,671
-29,863 Reduced 43.34%
39,039 $551,000
Q1 2020

May 15, 2020

BUY
$5.42 - $17.75 $373,448 - $1.22 Million
68,902 New
68,902 $634,000

Others Institutions Holding PRVB

# of Institutions
1
Shares Held
170K
Call Options Held
0
Put Options Held
0

About Provention Bio, Inc.


  • Ticker PRVB
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 81,549,904
  • Description
  • Provention Bio, Inc., a clinical stage biopharmaceutical company, focuses on the development and commercialization of therapeutics and solutions to intercept and prevent immune-mediated diseases. Its products candidates include PRV-031 teplizumab and monoclonal antibodies (mAb) that is in Phase III clinical trial for the interception of type one...
More about PRVB
Track This Portfolio

Track Jane Street Group, LLC Portfolio

Follow Jane Street Group, LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Jane Street Group, LLC, based on Form 13F filings with the SEC.

News

Stay updated on Jane Street Group, LLC with notifications on news.